181 related articles for article (PubMed ID: 29850112)
1. Tumor-infiltrating CD45RO
Hu Z; Gu X; Zhong R; Zhong H
J Thorac Dis; 2018 Apr; 10(4):2089-2099. PubMed ID: 29850112
[TBL] [Abstract][Full Text] [Related]
2. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
[TBL] [Abstract][Full Text] [Related]
3. [CD45RO⁺ Memory T Lymphocytes As A Candidate Marker for Non-small Cell Lung Cancer].
Tan Q; Li H; Yu M; Tang X; Tan J; Zhang S; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Apr; 24(4):254-264. PubMed ID: 33910273
[TBL] [Abstract][Full Text] [Related]
4. Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer.
Chen R; Gong Y; Zou D; Wang L; Yuan L; Zhou Q
PeerJ; 2019; 7():e7804. PubMed ID: 31616592
[TBL] [Abstract][Full Text] [Related]
5. Combined Evaluation of Tumor-Infiltrating CD8 + and FoxP3 + Lymphocytes Provides Accurate Prognosis in Stage IA Lung Adenocarcinoma.
Kinoshita F; Takada K; Yamada Y; Oku Y; Kosai K; Ono Y; Tanaka K; Wakasu S; Oba T; Osoegawa A; Tagawa T; Shimokawa M; Oda Y; Mori M
Ann Surg Oncol; 2020 Jun; 27(6):2102-2109. PubMed ID: 31773516
[TBL] [Abstract][Full Text] [Related]
6. CD8, FoxP3, and CD45RO+ Lymphocytic Infiltrates in Type I and Type II Endometrial Cancers in African American and European American Females.
Rashid T; Young-Pierce JL; Garrett-Mayer E; Graybill W; Neal S; Spruill LS
Int J Gynecol Pathol; 2017 Nov; 36(6):540-549. PubMed ID: 28114190
[TBL] [Abstract][Full Text] [Related]
7. High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma.
Rauser S; Langer R; Tschernitz S; Gais P; Jütting U; Feith M; Höfler H; Walch A
BMC Cancer; 2010 Nov; 10():608. PubMed ID: 21054833
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance and prognostic role of LAG3 + tumor-infiltrating lymphocytes in colorectal cancer; relationship with sidedness.
Tavana S; Mokhtari Z; Sanei MH; Heidari Z; Dehghanian AR; Faghih Z; Rezaei M
Cancer Cell Int; 2023 Feb; 23(1):23. PubMed ID: 36765348
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating CD45RO(+) memory cells are associated with a favorable prognosis breast cancer.
Yajima R; Yajima T; Fujii T; Yanagita Y; Fujisawa T; Miyamoto T; Tsutsumi S; Iijima M; Kuwano H
Breast Cancer; 2016 Jul; 23(4):668-74. PubMed ID: 26071015
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and prognostic analysis of 247 small cell lung cancer with limited-stage after surgery.
Liu L; Wei J; Teng F; Zhu Y; Xing P; Zhang J; Guo Y; Dong J; Ying J; Li J; Yang L
Hum Pathol; 2021 Feb; 108():84-92. PubMed ID: 33245986
[TBL] [Abstract][Full Text] [Related]
11. High Density of Intratumor CD45RO
Zhou C; Li J; Wu Y; Diao P; Yang J; Cheng J
J Oral Maxillofac Surg; 2019 Mar; 77(3):536-545. PubMed ID: 30395824
[TBL] [Abstract][Full Text] [Related]
12. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC).
Berghoff AS; Ricken G; Wilhelm D; Rajky O; Widhalm G; Dieckmann K; Birner P; Bartsch R; Preusser M
J Neurooncol; 2016 Oct; 130(1):19-29. PubMed ID: 27436101
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of intratumoral CD103+ tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma.
Koh J; Kim S; Kim MY; Go H; Jeon YK; Chung DH
Oncotarget; 2017 Feb; 8(8):13762-13769. PubMed ID: 28099920
[TBL] [Abstract][Full Text] [Related]
14. CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome.
Mohammadi Y; Ahmadvand S; Mirtalebi M; Ashraf MJ; Khademi B; Ghaderi A
Braz J Otorhinolaryngol; 2022; 88 Suppl 4(Suppl 4):S133-S142. PubMed ID: 36319566
[TBL] [Abstract][Full Text] [Related]
15. Distinct role of tumor-infiltrating lymphocytes between synchronous and metachronous colorectal cancer.
Imazu Y; Matsuo Y; Hokuto D; Yasuda S; Yoshikawa T; Kamitani N; Yoshida C; Sasaki T; Sho M
Langenbecks Arch Surg; 2023 Feb; 408(1):72. PubMed ID: 36720759
[TBL] [Abstract][Full Text] [Related]
16. CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer.
Chen J; He Q; Liu J; Xiao Y; Xiao C; Chen K; Xie D; Zhang X
Cancer Manag Res; 2018; 10():3505-3511. PubMed ID: 30271199
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of CD8CD45RO tumor infiltrating lymphocytes in patients with extrahepatic cholangiocarcinoma.
Kim R; Coppola D; Wang E; Chang YD; Kim Y; Anaya D; Kim DW
Oncotarget; 2018 May; 9(34):23366-23372. PubMed ID: 29805739
[TBL] [Abstract][Full Text] [Related]
18. Tumor-Infiltrating CD45RO
Ito N; Yamasaki S; Shintani T; Matsui K; Obayashi F; Koizumi K; Tani R; Yanamoto S; Okamoto T
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190149
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of CD45RO(+) tumor-infiltrating lymphocytes for locally advanced rectal cancer following 30 Gy/10f neoadjuvant radiotherapy.
Wang L; Zhai ZW; Ji DB; Li ZW; Gu J
Int J Colorectal Dis; 2015 Jun; 30(6):753-60. PubMed ID: 25935450
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]